Rituximab worth it in advanced-stage NHL?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.471, 2005-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced-Stage Follicular Lymphoma in the Rituximab Era: When Should Patients Receive Anthracycline-Based Chemotherapy?

By Pettengell Ruth

Drugs, Vol. 69, Iss. 13, 2009-09 ,pp. : 1727-1737

Adis International

Access to resources Recommend Favorite

Antivirals prevent AIDS-related NHL?

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Is it worth using lapatinib for advanced breast cancer?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rituximab: Spondylodiscitis?: case report

Reactions Weekly, Vol. 1, Iss. 1433, 2013-01 ,pp. : 39-39

Adis International

Access to resources Recommend Favorite

Rituximab: a revelation in RRMS?

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite